Back |
home / stock / lgnd / lgnd message board
Subject | By | Source | When |
---|---|---|---|
Stock Tracker: Latest Ligand Pharmaceuticals Inc (LGND) Headlines Bright Outlook at Ligand - Analyst | Stock_Tracker | investorshangout | 03/13/2014 2:33:20 PM |
chartguy89: LGND Stock Charts Last: -1.70 Saturday, March 1, 2014 at 7:16:36 PM $LGND 1 Mont | chartguy89 | investorshangout | 03/02/2014 12:16:48 AM |
chartguy89: LGND Stock Charts Last: -0.91 Friday, February 28, 2014 at 12:23:08 AM $LGND 1 M | chartguy89 | investorshangout | 02/28/2014 5:23:19 AM |
News, Short Squeeze, Breakout and More Instantly...
Ligand Pharmaceuticals Incorporated Company Name:
LGND Stock Symbol:
NASDAQ Market:
Ligand Pharmaceuticals Incorporated Website:
2024-07-09 10:30:11 ET Craig-Hallum analyst issues BUY recommendation for LGND on July 9, 2024 08:42AM ET. The previous analyst recommendation was Buy. LGND was trading at $86.88 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ana...
2024-07-09 10:00:05 ET Matt Hewitt from Craig-Hallum issued a price target of $140.00 for LGND on 2024-07-09 08:42:00. The adjusted price target was set to $140.00. At the time of the announcement, LGND was trading at $86.88. The overall price target consensus is at $117...
Acquisition provides Ligand with the royalty rights to QARZIBA®, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A. QARZIBA is the sixth key asset added to Ligand’s commercial stage portfolio since the b...